z-logo
Premium
The positive contributions of PowerLac ™ supplementation to the production performance, feed utilization and disease resistance of Nile tilapia Oreochromis niloticus (L.)
Author(s) -
Suprayudi Muhammad A,
Maeda Minoru,
Hidayatullah Hidayatullah,
Widanarni Widanarni,
Setiawati Mia,
Ekasari Julie
Publication year - 2017
Publication title -
aquaculture research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.646
H-Index - 89
eISSN - 1365-2109
pISSN - 1355-557X
DOI - 10.1111/are.13052
Subject(s) - nile tilapia , oreochromis , biology , probiotic , aeromonas hydrophila , zoology , tilapia , feed conversion ratio , weight gain , food science , lactobacillus , body weight , fishery , fish <actinopterygii> , bacteria , endocrinology , fermentation , genetics
The objective of this research was to determine the optimum dietary supplementation level of a probiotic (PowerLac ™ ), for improving Nile tilapia Oreochromis niloticus growth performance and feed utilization, as well as enhanced protection against disease. For laboratory experimentation, a completely randomized experimental design, consisting of four treatments of a dietary probiotic (PowerLac ™ , containing Lactobacillus lactis D1813) supplementation at different levels (0.25, 0.5, 1.0 and 2.0 g kg −1 ), against a control (0 g kg −1 ), was performed for 8 weeks (of culture period). For field experiments, three treatments of different dietary probiotic supplementation levels (0.25, 0.5 and 1.0 g kg −1 ), plus a control, were employed for 22 weeks (of culture period). Under controlled experimental conditions, in the first experiment, significantly higher fish final body weight, growth and lower food conversion ratio ( FCR ) were achieved by treatments with dietary probiotic supplementations of 0.25 and 0.5 g kg −1 ( P  < 0.05). In strong partial support of this, at field experimentation level, a dietary PowerLac ™ supplementation of 0.5 g kg −1 showed the most pronounced results, as indicated by the higher growth, and protein and lipid retention, as well as lower FCR , and reduced mortality following the Aeromonas hydrophila challenge test ( P  < 0.05).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom